Institute

Health Ministry Denies Reports Of Rejection Of SII, Bharat Biotech Emergency Use Authorisation

SII Corona Vaccine Cost: Serum Institute Getting Closer To Signing Deal, Likely To Sell A Dose For Rs 250

Bharat Biotech Applies For Emergency Authorization Of 'Covaxin', Becomes Second Indian Company To Seek Approval

Corona Vaccine: Serum Institute Becomes First Indian Pharma To Seek Nod For Emergency Use Of Oxford Vaccine In India

PM Modi To Hold An All Party Meet On Dec 4 For Covid-19 Vaccine Roadmap

'Applying For Emergency Use Of Covid Vaccine In 2 Weeks', Says Serum Institute's Adar Poonawalla After PM Modi's Visit

Narendra Modi Pune Visit HIGHLIGHTS: After PM's Visit, SII CEO Says In Process Of Getting Emergency License For Vaccine

PM Modi Visits Zydus, Bharat Biotech, SII Labs To Review Corona Vaccine Development - All You Need To Know

Why AstraZeneca, Oxford 'Covishield' Vaccine A Better Fit Over Pfizer And Moderna Shots In India

COVID-19 Vaccine Update: Oxford Vaccine To Be Available For Public By April Next Year | Price, Efficacy & All You Need To Know

Vaccine Update: Serum Institute Completes Enrolment For Phase 3 Trials Of Oxford Covid-19 Vaccine

Covid-19 Vaccine 'Covishield' To Be Ready By Jan 2021, Says Serum Institute CEO Adar Poonawalla